- The 2nd Menopause & HIV Webinar successfully took place on Tuesday, 21 January 2025 at 16:00 - 17:30 CET.
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
2nd Menopause & HIV Webinar 2025
Related Enduring Materials
Enduring Materials
Enduring Materials
2nd Menopause & HIV Webinar 2025 -
Susanna Weidlinger, MD
How to Support Women Living with HIV during Transition to Menopause
University Department of Gynaecological Endocrinology and Reproductive Medicine, Inselspital Bern / Swiss Society of Gynaecological Endocrinology, Contraception and Menopause, Switzerland
Co-morbidities Screening and Prevention for Women After Menopause
HIV & Menopause - Community Perspective
Overview
General
About this Webinar
Menopause is a transition phase in aging women that is associated with hormonal changes that increase the risk for cardiovascular, bone, and neurocognitive diseases. Women in menopause are also at higher risk of acquiring HIV. However, little is known about the relationship between HIV and menopause.
Women living with HIV enter menopause 3-5 years earlier than those living without the virus. They experience more severe symptoms and show a higher risk for co-morbidities compared to women living without HIV. Severe menopausal symptoms have been associated with reduced quality of life, poorer mental health, and reduced adherence to HIV care.
Overall, monitoring and clinical management of menopause-related comorbidities and symptoms in women living with HIV becomes burdensome when there are limited official guidelines.
To meet this need, this program will gather a diverse audience of researchers, healthcare professionals, pharmacologists, regulatory, and community representatives to increase awareness about the interplay of HIV and menopause. A dialogue will be stimulated with the aim of improving the management of symptoms, co-morbidities, and quality of life in women who experience menopause and are living with HIV.
Program Chair
General Information
Who Should Attend?
- Clinicians focusing on HIV
- Researchers
- General practitioners
- Gynaecologists
- Pharmacologists
- Regulatory representatives
- Patient community representatives
- Industry representatives
- Researchers
- General practitioners
- Gynaecologists
- Pharmacologists
- Regulatory representatives
- Patient community representatives
- Industry representatives
Meeting Objectives
This meeting aims to:
• Increase awareness on challenges faced by women living with HIV and experiencing menopause;
• Stimulate discussion among participants of different backgrounds on appropriate management of conditions that appear in women living with HIV and experiencing menopause.
• Increase awareness on challenges faced by women living with HIV and experiencing menopause;
• Stimulate discussion among participants of different backgrounds on appropriate management of conditions that appear in women living with HIV and experiencing menopause.
Learning Objectives
After participating in this activity, participants will be able to:
• Summarize symptoms and other challenges faced by women living with HIV and experiencing menopause;
• Outline latest data on treatment regimens and pharmacological characteristics;
• Reflect on strategies to manage menopausal symptoms in women living with HIV.
• Summarize symptoms and other challenges faced by women living with HIV and experiencing menopause;
• Outline latest data on treatment regimens and pharmacological characteristics;
• Reflect on strategies to manage menopausal symptoms in women living with HIV.
Practical Information
Certificate of Attendance
A digital certificate of attendance will be sent to you after successfully completing the program and post-webinar survey.
Language
The official language of the webinar is English
Enduring Materials
Provided the Speakers' Permission, video recordings and presentation slides will be available shortly after the completion of the webinar.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Accreditation
EACCME® Accreditation Statement
The 2nd Menopause & HIV Webinar 2025, Virtual, Netherlands, 21/01/2025 - 21/01/2025 organized by Virology Education B.V. has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credit (ECMEC®). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities occurring outside of Canada, recognized by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Support
Support
The 2nd Menopause & HIV Webinar 2025 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Endorsers
Previous Editions
Previous Editions
Language
Related Programs
